Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global public health crisis. Effective COVID-19 vaccines developed by Pfizer-BioNTech, Moderna, and Astra Zeneca have made significant impacts in controlling the COVID-19 burden, especially in reducing the transmission of SARS...

תיאור מלא

מידע ביבליוגרפי
Autores principales: Lim, Hui Xuan, Masomian, Malihe, Khalid, Kanwal, Kumar, Asqwin Uthaya, MacAry, Paul A., Poh, Chit Laa
פורמט: Online Artículo Texto
שפה:English
יצא לאור: MDPI 2022
נושאים:
Review
גישה מקוונת:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029629/
https://www.ncbi.nlm.nih.gov/pubmed/35457159
http://dx.doi.org/10.3390/ijms23084341

אינטרנט

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029629/
https://www.ncbi.nlm.nih.gov/pubmed/35457159
http://dx.doi.org/10.3390/ijms23084341

פריטים דומים